Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425404/ |
id |
pubmed-3425404 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-34254042013-09-01 Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function Long, S. Alice Rieck, Mary Sanda, Srinath Bollyky, Jennifer B. Samuels, Peter L. Goland, Robin Ahmann, Andrew Rabinovitch, Alex Aggarwal, Sudeepta Phippard, Deborah Turka, Laurence A. Ehlers, Mario R. Bianchine, Peter J. Boyle, Karen D. Adah, Steven A. Bluestone, Jeffrey A. Buckner, Jane H. Greenbaum, Carla J. Immunology and Transplantation American Diabetes Association 2012-09 2012-08-17 /pmc/articles/PMC3425404/ /pubmed/22721971 http://dx.doi.org/10.2337/db12-0049 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Long, S. Alice Rieck, Mary Sanda, Srinath Bollyky, Jennifer B. Samuels, Peter L. Goland, Robin Ahmann, Andrew Rabinovitch, Alex Aggarwal, Sudeepta Phippard, Deborah Turka, Laurence A. Ehlers, Mario R. Bianchine, Peter J. Boyle, Karen D. Adah, Steven A. Bluestone, Jeffrey A. Buckner, Jane H. Greenbaum, Carla J. |
spellingShingle |
Long, S. Alice Rieck, Mary Sanda, Srinath Bollyky, Jennifer B. Samuels, Peter L. Goland, Robin Ahmann, Andrew Rabinovitch, Alex Aggarwal, Sudeepta Phippard, Deborah Turka, Laurence A. Ehlers, Mario R. Bianchine, Peter J. Boyle, Karen D. Adah, Steven A. Bluestone, Jeffrey A. Buckner, Jane H. Greenbaum, Carla J. Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
author_facet |
Long, S. Alice Rieck, Mary Sanda, Srinath Bollyky, Jennifer B. Samuels, Peter L. Goland, Robin Ahmann, Andrew Rabinovitch, Alex Aggarwal, Sudeepta Phippard, Deborah Turka, Laurence A. Ehlers, Mario R. Bianchine, Peter J. Boyle, Karen D. Adah, Steven A. Bluestone, Jeffrey A. Buckner, Jane H. Greenbaum, Carla J. |
author_sort |
Long, S. Alice |
title |
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
title_short |
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
title_full |
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
title_fullStr |
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
title_full_unstemmed |
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function |
title_sort |
rapamycin/il-2 combination therapy in patients with type 1 diabetes augments tregs yet transiently impairs β-cell function |
description |
|
publisher |
American Diabetes Association |
publishDate |
2012 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425404/ |
_version_ |
1611551524092116992 |